ATE121618T1 - Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien. - Google Patents

Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.

Info

Publication number
ATE121618T1
ATE121618T1 AT91917082T AT91917082T ATE121618T1 AT E121618 T1 ATE121618 T1 AT E121618T1 AT 91917082 T AT91917082 T AT 91917082T AT 91917082 T AT91917082 T AT 91917082T AT E121618 T1 ATE121618 T1 AT E121618T1
Authority
AT
Austria
Prior art keywords
calories
carbon atoms
colloidal particles
particles
bicarbonate
Prior art date
Application number
AT91917082T
Other languages
English (en)
Inventor
David W Yesair
Original Assignee
David W Yesair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David W Yesair filed Critical David W Yesair
Application granted granted Critical
Publication of ATE121618T1 publication Critical patent/ATE121618T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91917082T 1990-08-13 1991-08-12 Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien. ATE121618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56724390A 1990-08-13 1990-08-13

Publications (1)

Publication Number Publication Date
ATE121618T1 true ATE121618T1 (de) 1995-05-15

Family

ID=24266341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917082T ATE121618T1 (de) 1990-08-13 1991-08-12 Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.

Country Status (9)

Country Link
US (3) US5314921A (de)
EP (1) EP0543943B1 (de)
JP (1) JP3273785B2 (de)
AT (1) ATE121618T1 (de)
AU (1) AU666293B2 (de)
CA (1) CA2089003C (de)
DE (1) DE69109297T2 (de)
ES (1) ES2071332T3 (de)
WO (1) WO1992003121A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2071332T3 (es) * 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
AU680355B2 (en) * 1994-03-14 1997-07-24 Eurovita A/S A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes
EP0835097B1 (de) * 1995-06-06 2001-08-29 Biomolecular Products, Inc. Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
CA2281755C (en) * 1997-02-24 2006-11-07 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6426069B1 (en) * 1998-09-08 2002-07-30 Biomolecular Products, Inc. Method and compositions for increasing intestinal absorption of fats
US6172122B1 (en) 1998-12-17 2001-01-09 The Lubrizol Corporation Stable emulsions from gelled overbased substrates with surfactants and aqueous liquids
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6861060B1 (en) 2000-04-21 2005-03-01 Elena Luriya Personal care formulations
WO2002058689A1 (en) * 2000-12-05 2002-08-01 Childrens Hospital Los Angeles Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
EP1434593B1 (de) 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFIKATIONEN FESTER 3-sn-PHOSPHOGLYCERIDE
US20050008686A1 (en) * 2003-01-15 2005-01-13 Mannino Raphael J. Cochleate preparations of fragile nutrients
ES2581184T3 (es) * 2003-01-31 2016-09-01 Childrens Hospital Los Angeles Composiciones orales de fenretinida que tienen mayor biodisponibilidad y métodos de uso de las mismas
ES2297111T3 (es) * 2003-09-18 2008-05-01 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Composicion farmaceutica de clorhidrato de diltiazem estable para aplicacion cutanea y proceso para su preparacion.
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
EP2013016B8 (de) 2006-03-29 2014-10-08 Wayne State University Liposomale nanopartikel und andere fenretinid-formulierungen für die therapie und wirkstofffreisetzung
EP2200613B1 (de) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazin-derivate und ihre verwendungen
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (de) 2018-07-20 2026-04-01 Lipocine Inc. Orale pharmazeutische zusammensetzung mit testosterontridecanoat und/oder testosterondodecanoat zur behandlung von lebererkrankungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
JPS5321393B2 (de) * 1974-10-19 1978-07-03
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
FR2497668B1 (fr) * 1981-01-15 1986-03-21 Gattefosse Ets Sa Emulsions lipoproteiques injectables, leur procede de preparation et leurs applications en therapeutique
JPS57167926A (en) * 1981-04-08 1982-10-16 Mitsubishi Chem Ind Ltd External base for skin
WO1983000294A1 (en) * 1981-07-23 1983-02-03 Little Inc A Micellular drug delivery system
US4454113A (en) * 1982-09-21 1984-06-12 Scm Corporation Stabilization of oil and water emulsions using polyglycerol esters of fatty acids
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) * 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
ES2071332T3 (es) * 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.

Also Published As

Publication number Publication date
DE69109297T2 (de) 1995-11-09
AU666293B2 (en) 1996-02-08
CA2089003C (en) 2001-03-20
AU8646291A (en) 1992-03-17
WO1992003121A1 (en) 1992-03-05
US5741822A (en) 1998-04-21
US5707873A (en) 1998-01-13
DE69109297D1 (de) 1995-06-01
EP0543943B1 (de) 1995-04-26
JP3273785B2 (ja) 2002-04-15
CA2089003A1 (en) 1992-02-14
JPH06503815A (ja) 1994-04-28
US5314921A (en) 1994-05-24
EP0543943A1 (de) 1993-06-02
ES2071332T3 (es) 1995-06-16

Similar Documents

Publication Publication Date Title
DE69109297D1 (de) Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
DE69420419D1 (de) Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
ZA200005915B (en) Pharmaceutical compositions capable of being gelled.
MY110734A (en) Improvements in or relating to dioic acids.
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
AU531878B2 (en) Medicated animal feed based on liver meal
AU2671292A (en) Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
SI9520139B (sl) Halkoni in njihovi estri z antiproliferativno učinkovitostjo na tumorje maternice, jajčnikov in dojk
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
AU563273B2 (en) Composition containing an essential fatty acid and niacin and/or a bile salt binder
EP0084052A1 (de) Verabreichungssystem für mizellulare arzneimittel
DE69614855D1 (de) Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
EP0238198A3 (de) Verfahren zur Abänderung der Lipid-Struktur-Funktion und von Zellmembranen und pharmazeutische Zusammensetzungen zur Verwendung dabei
GR3034803T3 (en) Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
AU7338587A (en) Pharmaceutical compositions of furosemide, piretanide or lemidosul in a fatty acid alkanolamide base
ES2172172T3 (es) Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion.
GB8804188D0 (en) Pharmaceutical compositions
YU48388B (sh) Postupak za dobijanje farmaceutske masti koja ne iritira kožu
JPS5640607A (en) Drug composition
DK576086A (da) Blanding til afgivelse af oralt indgivelige stoffer
UA33167A (uk) Комбінована мазь для лікування ран "мазь фенітол"
TH15810A (th) สูตรผสมที่มีกรดแฟททีชนิดไม่อิ่มตัว

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee